Netcall (NET) Competitors

Netcall (LON:NET) and Dr. Martens (LON:DOCS) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk.

Do analysts prefer NET or DOCS?

Netcall currently has a consensus price target of GBX 130, suggesting a potential upside of 13.67%. Given Netcall's stronger consensus rating and higher probable upside, analysts clearly believe Netcall is more favorable than Dr. Martens.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Netcall	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Dr. Martens	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has higher valuation and earnings, NET or DOCS?

Dr. Martens has higher revenue and earnings than Netcall. Dr. Martens is trading at a lower price-to-earnings ratio than Netcall, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Netcall	£39.16M	4.83	£5.87M	£3.55	32.21
Dr. Martens	£874.20M	0.59	£68.97M	£7.05	7.50

Do institutionals & insiders hold more shares of NET or DOCS?

69.3% of Netcall shares are held by institutional investors. Comparatively, 69.5% of Dr. Martens shares are held by institutional investors. 11.5% of Netcall shares are held by insiders. Comparatively, 4.4% of Dr. Martens shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Is NET or DOCS a better dividend stock?

Netcall pays an annual dividend of GBX 1 per share and has a dividend yield of 0.9%. Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 5.7%. Netcall pays out 28.2% of its earnings in the form of a dividend. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Is NET or DOCS more profitable?

Netcall has a net margin of 14.99% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat Netcall's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Netcall	14.99%	14.95%	4.62%
Dr. Martens	7.89%	18.91%	8.12%

Which has more volatility & risk, NET or DOCS?

Netcall has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Comparatively, Dr. Martens has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500.

Does the MarketBeat Community prefer NET or DOCS?

Netcall received 152 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 58.21% of users gave Netcall an outperform vote.

Company	Underperform	Outperform
Netcall	Outperform Votes 163 58.21%	Underperform Votes 117 41.79%
Dr. Martens	Outperform Votes 11 91.67%	Underperform Votes 1 8.33%

Does the media favor NET or DOCS?

In the previous week, Dr. Martens had 1 more articles in the media than Netcall. MarketBeat recorded 4 mentions for Dr. Martens and 3 mentions for Netcall. Dr. Martens' average media sentiment score of 1.35 beat Netcall's score of 0.30 indicating that Dr. Martens is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Netcall	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Dr. Martens	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Netcall and Dr. Martens tied by winning 10 of the 20 factors compared between the two stocks.